共 50 条
- [41] Can expression of interferon-stimulated genes in pre-treatment liver biopsy of chronic hepatitis B patients predict therapy response and long-term HBV infection outcome?HEPATOLOGY, 2014, 60 : 531A - 531ACarey, IvanaChilds, KateBansal, SanjayTizzard, SarahBruce, Matthew J.Horner, MaryVergani, DiegoAgarwal, KoshMieli-Vergani, Giorgina
- [42] PEG-Interferon α-2b+ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b+ribavirin therapy.GASTROENTEROLOGY, 2003, 124 (04) : A783 - A783Sulkowski, MRothstein, KStein, LGodofsky, EGoodman, RDieterich, D
- [43] HBSAG and anti-HBE positive patients with chronic hepatitis and intermediate serum HBV DNA levels and no or only slight hepatic fibrosis might respond substantially better to treatment with interferon α12B.GASTROENTEROLOGY, 1999, 116 (04) : A1283 - A1283ter Borg, Ften Kate, FJWCuypers, HTMLeentvaar-Kuijpers, AOosting, JWertheim-van Dillen, PMEHonkoop, Pde Man, RARasch, MCHoek, FJChamulea, RAFMReesink, HW
- [44] PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.HEPATOLOGY, 2001, 34 (04) : 419A - 419ASulkowski, MRothstein, KDStein, LGodofsky, EShoultz, DHudnall, RHuff, MDieterich, D
- [45] Comparisons the durability of 6 months and 12 months prolonged treatment duration after cessation chemotherapy in chronic hepatitis B patients with prophylaxis antiviral therapy: A open level randomized clinical trialJOURNAL OF HEPATOLOGY, 2018, 68 : S111 - S111Hu, T. -H.Tseng, P. -L.Tsai, M. C.Chang, K. -C.Yen, Y. -H.
- [46] The Single Nucleotide Polymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B Patients Treated With Pegylated Interferon: Multicenter StudyGASTROENTEROLOGY, 2015, 148 (04) : S1066 - S1066Thanapirom, KessarinSuksawatamnuay, SirinpornPoovorawan, KittiyodSukeepaisarnjaroen, WattanaTanwandee, TawesakThongsawat, SatawatLeerapun, ApinyaPiratvisuth, TeerhaBoonsirichan, RattanaBunchorntavakul, ChalermratPattanasirigool, ChaowalitPornthisarn, BubphaTantipanichtheerakul, SupotSripariwuth, EkaweeJeamsripong, WoramonSanpajit, TheeranunKomolmit, Piyawat
- [47] Prospective analysis of sustained virologic response (SVR) to PEG-interferon (PEG IFN) alfa-2b and ribavirin treatment in Asian and Hispanic patients with chronic hepatitis C: Results from the WIN-R trialHEPATOLOGY, 2006, 44 (04) : 320A - 321AFreilich, BradleyHu, Ke-qinJacobson, IraBrown, RobertAfdhal, NezamKwo, PaulSantoro, JohnBecker, ScottWakil, AdilPound, DavidGodofsky, EliotStrauss, RobertBernstein, DavidFlamm, StevenBala, NatarajanAraya, VictorGriffel, LouisBrass, Clifford
- [48] Two-weeks induction therapy with pegylated interferon decreases early viral load without improving sustained virological response rate in patients with chronic hepatitis C - Prospective, randomized, open label phase III clinical trialGASTROENTEROLOGY, 2004, 126 (04) : A694 - A694Vogel, WBrunner, HLin, WStauber, RGschwantler, MStadler, BUlmer, H
- [49] CHANGES OF HBsAg QUANTITY AND ITS RELATION WITH HBEAG SEROCONVERSION FOLLOWING 48 WEEKS PEGYLATED-INTERFERON-ALPHA TREATMENT IN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B AFTER LONG TERM NUCLEOS(T)IDE ANALOGUE MAINTENANCE THERAPY; ROLL OVER TRIALHEPATOLOGY, 2020, 72 : 477A - 478AWoo, Hyun YoungHeo, JeongTak, Won-YoungLee, Heon JuChung, Woo JinPark, Soo YoungKweon, Young-Oh
- [50] HEPATIC STEATOSIS AND SERUM GLUCOSE NEGATIVELY AFFECT SUSTAINED VIROLOGIC RESPONSE (SVR) AFTER TREATMENT WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN (PEG-IFN/RBV) IN CHRONIC HEPATITIS C (CH-C) PATIENTS CARRYING IL28B NON-"CC" GENOTYPEHEPATOLOGY, 2011, 54 : 1142A - 1142AGuragain, RicheshEstep, J. MichaelAfendy, ArianStepanova, MariaChandhoke, VikasBaranova, AnchaYounossi, Zobair M.